1.31 USD
-0.18
12.08%
At close Apr 21, 4:00 PM EDT
After hours
1.33
+0.02
1.53%
1 day
-12.08%
5 days
-20.12%
1 month
-34.83%
3 months
-51.48%
6 months
-56.33%
Year to date
-53.55%
1 year
-63.91%
5 years
138.40%
10 years
-69.95%
 

About: Aemetis Inc is an renewable fuel and biochemicals company focused on the production of renewable fuels and chemicals through the acquisition, development and commercialization of technologies that replace traditional petroleum-based products through the conversion of first-generation ethanol and biodiesel plants into biorefineries. It owns and operates an approximately 65 million gallon per year ethanol production facility located in Keyes, California. In addition to low carbon renewable fuel ethanol, the Keyes Plant produces Wet Distillers Grains, Distillers Corn Oil, and Condensed Distillers Solubles, all of which are sold to local dairies and feedlots as animal feed. It operates in the reportable geographic segments of North America and India.

Employees: 223

0
Funds holding %
of 7,419 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

192% more repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 12

86% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 7

28% more capital invested

Capital invested by funds: $25.9M [Q3] → $33.1M (+$7.24M) [Q4]

7% more funds holding

Funds holding: 70 [Q3] → 75 (+5) [Q4]

0.9% more ownership

Funds ownership: 23.84% [Q3] → 24.74% (+0.9%) [Q4]

38% less call options, than puts

Call options by funds: $969K | Put options by funds: $1.56M

Research analyst outlook

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$19
1,350%
upside
Avg. target
$24
1,694%
upside
High target
$28
2,037%
upside

2 analyst ratings

positive
100%
neutral
0%
negative
0%
Ascendiant Capital
Edward Woo
29% 1-year accuracy
23 / 80 met price target
1,350%upside
$19
Buy
Maintained
17 Mar 2025
HC Wainwright & Co.
Amit Dayal
18% 1-year accuracy
22 / 122 met price target
2,037%upside
$28
Buy
Reiterated
14 Mar 2025

Financial journalist opinion

Based on 4 articles about AMTX published over the past 30 days

Neutral
MCAP MediaWire
12 hours ago
Aemetis India Plant Receives $31 million of Biodiesel Orders from OMCs for Delivery in Next Three Months
Listen: CUPERTINO, Calif., April 21, 2025 – PRISM MediaWire – Aemetis, Inc.
Aemetis India Plant Receives $31 million of Biodiesel Orders from OMCs for Delivery in Next Three Months
Neutral
GlobeNewsWire
12 hours ago
Aemetis India Plant Receives $31 million of Biodiesel Orders from OMCs for Delivery in Next Three Months
CUPERTINO, Calif., April 21, 2025 (GLOBE NEWSWIRE) -- Aemetis, Inc. (NASDAQ: AMTX), a diversified global renewable natural gas and biofuels company, announced the Company's subsidiary in India, Universal Biofuels, received multiple orders for an aggregate of $31 million for the delivery during May, June and July of more than 33,000 kiloliters of biodiesel to the three government-owned Oil Marketing Companies (OMCs).
Aemetis India Plant Receives $31 million of Biodiesel Orders from OMCs for Delivery in Next Three Months
Neutral
MCAP MediaWire
1 week ago
Aemetis Biogas Monthly RNG Production Increased by 55% in March
Sales of LCFS credits and D3 RINs completed at the end of Q1 CUPERTINO, Calif., April 08, 2025 – PRISM MediaWire – Aemetis, Inc.
Aemetis Biogas Monthly RNG Production Increased by 55% in March
Neutral
Newsfile Corp
3 weeks ago
Stonegate Capital Partners Updates Coverage on Aemetis, Inc. (AMTX) Q4 2024
Dallas, Texas--(Newsfile Corp. - March 28, 2025) - Aemetis, Inc. (NASDAQ: AMTX): Stonegate Capital Partners updates coverage on Aemetis, Inc. (NASDAQ: AMTX), highlighting strong growth across its renewable energy segments. Full year revenues increased 43% to $268.0M, up from $187.0M in FY23.
Stonegate Capital Partners Updates Coverage on Aemetis, Inc. (AMTX) Q4 2024
Neutral
Seeking Alpha
1 month ago
Aemetis, Inc. (AMTX) Q4 2024 Earnings Call Transcript
Aemetis, Inc. (NASDAQ:AMTX ) Q4 2024 Earnings Conference Call March 13, 2025 2:00 PM ET Company Participants Todd Waltz - EVP, CFO Eric McAfee - Founder, Chairman and CEO Andy Foster - President of Aemetis Advanced Fuels Conference Call Participants Jordan Levy - Truist Securities Sameer Joshi - HC Wainwright Derrick Whitfield - Texas Capital Matthew Blair - Tudor, Pickering, Holt & Co Dave Storms - Stonegate Ed Woo - Ascendiant Capital Operator Welcome to the Aemetis Fourth Quarter and Year End 2024 Earnings Review Conference Call. At this time, all participants are in a listen-only mode.
Aemetis, Inc. (AMTX) Q4 2024 Earnings Call Transcript
Neutral
Seeking Alpha
3 months ago
Undercovered Dozen: LexinFintech, Aemetis, HashiCorp, CubeSmart +
The 'Undercovered' Dozen series highlights 12 lesser-covered stocks, offering fresh investment ideas and encouraging discussion among investors. AI-driven lending, exemplified by Pagaya Technologies, is poised for significant growth, offering enhanced decision-making and operational efficiencies. Ahan Vashi makes this their top pick for 2025. Ambev S.A. faces challenges due to Brazil's adverse economic conditions, limiting long-term capital gains and justifying a bearish outlook according to Bernard Zambonin.
Undercovered Dozen: LexinFintech, Aemetis, HashiCorp, CubeSmart +
Negative
Seeking Alpha
4 months ago
Aemetis: I Have Serious Concerns
Aemetis faces severe financial distress, with their SEC Filing raising "substantial doubts" about their ability to "continue as a going concern". Most notably, they face impending debt maturities as well as a lack of profitability with almost non-existent gross margins. Their equity issuances are highly dilutive due to a weak share price, and thus they are not a viable strategy to relieve their financial distress.
Aemetis: I Have Serious Concerns
Neutral
Newsfile Corp
4 months ago
Stonegate Capital Partners Updates Coverage on Aemetis, Inc. (AMTX) Q3 2024
Dallas, Texas--(Newsfile Corp. - December 11, 2024) - Aemetis, Inc. (NASDAQ: AMTX): Stonegate Capital Partners updates coverage on Aemetis, Inc. (NASDAQ: AMTX). Aemetis outlined a 5-year plan to reach $2.0B in revenue and $644M in adjusted EBITDA by 2028 vs F23 revenue and adjusted EBITDA of $186.7M and $(22.4)M.
Stonegate Capital Partners Updates Coverage on Aemetis, Inc. (AMTX) Q3 2024
Neutral
Seeking Alpha
5 months ago
Aemetis, Inc. (AMTX) Q3 2024 Earnings Call Transcript
Aemetis, Inc. (NASDAQ:AMTX ) Q3 2024 Earnings Call November 12, 2024 2:00 PM ET Company Participants Todd Waltz - Executive Vice President and Chief Financial Officer Eric McAfee - Founder, Chairman and Chief Executive Officer Andy Foster - President, North America Conference Call Participants Manav Gupta - UBS Henry Stephen - Truist Amit Dayal - H.C. Wainwright Matthew Blair - TPH Dave Storms - Stonegate Ed Woo - Ascendiant Capital Operator Good day, ladies and gentlemen, and welcome to the Aemetis Third Quarter 2024 Earnings Review Conference Call.
Aemetis, Inc. (AMTX) Q3 2024 Earnings Call Transcript
Negative
Zacks Investment Research
5 months ago
Aemetis (AMTX) Reports Q3 Loss, Tops Revenue Estimates
Aemetis (AMTX) came out with a quarterly loss of $0.38 per share versus the Zacks Consensus Estimate of a loss of $0.47. This compares to loss of $0.59 per share a year ago.
Aemetis (AMTX) Reports Q3 Loss, Tops Revenue Estimates
Charts implemented using Lightweight Charts™